Related Experiment Video
Updated: Jul 4, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Evidence of platelet activation in multiple sclerosis
William A Sheremata1, Wenche Jy, Lawrence L Horstman
1Multiple Sclerosis Center and Department of Neurology Miller School of Medicine, University of Miami, Miami, Florida, USA. sheremaw@bellsouth.net
Objective:
A fatality in one multiple sclerosis (MS) patient due to acute idiopathic thrombocytopenic purpura (ITP) and a near fatality in another stimulated our interest in platelet function abnormalities in MS. Previously, we presented evidence of platelet activation in a small cohort of treatment-naive MS patients.
Methods:
In this report, 92 normal controls and 33 stable, untreated MS patients were studied. Platelet counts, measures of platelet activation [plasma platelet microparticles (PMP), P-selectin expression (CD62p), circulating platelet microaggragtes (PAg)], as well as platelet-associated IgG/IgM, were carried out. In addition, plasma protein S activity was measured.
Results:
Compared to controls, PMP were significantly elevated in MS (p < 0.001) and CD62p expression was also markedly elevated (p < 0.001). Both are markers of platelet activation. Platelet-associated IgM, but not IgG, was marginally elevated in MS (p = 0.01). Protein S in MS patients did not differ significantly from normal values.
Conclusion:
Platelets are significantly activated in MS patients. The mechanisms underlying this activation and its significance to MS are unknown. Additional study of platelet activation and function in MS patients is warranted.
Insights
Platelets show significant activation in multiple sclerosis (MS) patients, indicated by elevated markers. Further research is needed to understand the causes and implications of this platelet activation in MS.
Area of Science:
- Neurology
- Hematology
- Immunology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease.
- Previous studies suggested platelet activation in treatment-naive MS patients.
- Severe bleeding events prompted investigation into platelet function abnormalities in MS.
Purpose of the Study:
- To investigate platelet activation and function in stable, untreated multiple sclerosis (MS) patients.
- To compare platelet activation markers in MS patients versus healthy controls.
Main Methods:
- Studied 33 stable, untreated MS patients and 92 healthy controls.
- Measured platelet counts, plasma platelet microparticles (PMP), P-selectin expression (CD62p), circulating platelet microaggregates (PAg), and platelet-associated IgG/IgM.
- Assessed plasma protein S activity.
Main Results:
- MS patients exhibited significantly elevated PMP (p < 0.001) and CD62p expression (p < 0.001) compared to controls, indicating increased platelet activation.
- Platelet-associated IgM was marginally elevated in MS patients (p = 0.01), but IgG levels did not differ significantly.
- Plasma protein S activity showed no significant difference between MS patients and controls.
Conclusions:
- Platelets are demonstrably activated in multiple sclerosis patients.
- The underlying mechanisms and clinical significance of platelet activation in MS remain undetermined.
- Further investigation into platelet activation and function in MS is warranted.
Related Concept Videos
Multiple Sclerosis l: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...

